VUDALIMAB for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where VUDALIMAB was used for Prostate cancer.
Most Reported Side Effects for VUDALIMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Anaemia | 21 | 31.8% | 3 | 19 |
| C-reactive protein increased | 20 | 30.3% | 7 | 20 |
| Pyrexia | 18 | 27.3% | 0 | 16 |
| Malignant neoplasm progression | 13 | 19.7% | 5 | 11 |
| Pneumonia | 13 | 19.7% | 2 | 13 |
| Dyspnoea | 12 | 18.2% | 1 | 11 |
| Nausea | 12 | 18.2% | 6 | 11 |
| Platelet count decreased | 12 | 18.2% | 1 | 10 |
| Hypoxia | 10 | 15.2% | 2 | 10 |
| Vomiting | 10 | 15.2% | 0 | 10 |
| Abdominal pain | 9 | 13.6% | 7 | 9 |
| Asthenia | 9 | 13.6% | 0 | 8 |
| Fatigue | 9 | 13.6% | 1 | 6 |
| Hypotension | 9 | 13.6% | 1 | 9 |
| Blood creatinine increased | 8 | 12.1% | 0 | 8 |
Other Indications for VUDALIMAB
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)